The Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor Gamma Gene Modifies the Association of Physical Activity and Body Mass Changes in Polish Women

被引:18
|
作者
Zarebska, Aleksandra [1 ]
Jastrzebski, Zbigniew [1 ]
Cieszczyk, Pawel [2 ]
Leonska-Duniec, Agata [2 ]
Kotarska, Katarzyna [2 ]
Kaczmarczyk, Mariusz [2 ]
Sawczuk, Marek [2 ]
Maciejewska-Karlowska, Agnieszka [2 ]
机构
[1] Gdansk Univ Phys Educ & Sport, Fac Tourism & Recreat, PL-80336 Gdansk, Poland
[2] Univ Szczecin, Fac Phys Educ & Hlth Promot, PL-71065 Szczecin, Poland
关键词
PPAR-GAMMA; ALANINE SUBSTITUTION; INSULIN SENSITIVITY; PPAR-GAMMA-2; GENE; OBESITY; VARIANT; INDEX; PROMOTER; IDENTIFICATION; ADIPOSITY;
D O I
10.1155/2014/373782
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Peroxisome proliferator-activated receptor gamma is a key regulator of adipogenesis, responsible for fatty acid storage and maintaining energy balance in the human body. Studies on the functional importance of the PPARG Pro12Ala polymorphic variants indicated that the observed alleles may influence body mass measurements; however, obtained results were inconsistent. We have decided to check if body mass changes observed in physically active participants will be modulated by the PPARG Pro12Ala genotype. The genotype distribution of the PPARG Pro12Ala allele was examined in a group of 201 Polish women measured for selected body mass variables before and after the completion of a 12-week training program. The results of our experiment suggest that PPARG genotype can modulate training-induced body mass measurements changes: after completion of the training program, Pro12/Pro12 homozygotes were characterised by a greater decrease of body fat mass measurements in comparison with 12Ala allele carriers. These results indicate that the PPARG 12Ala variant may impair the training-induced positive effects on body mass measurements; however, the detailed mechanism of such interaction remained unclear and observed correlation between PPARG genotype and body mass differential effects should be interpreted with caution.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population
    Li, Lin
    Cheng, Long-Xian
    Nsenga, Ripen
    He, Mei-An
    Wu, Tang-Chun
    CLINICAL CARDIOLOGY, 2006, 29 (07) : 300 - 304
  • [32] Association of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor γ2 with decreased basic metabolic rate in women with polycystic ovary syndrome
    Koika, Vasiliki
    Marioli, Dimitra J.
    Saltamavros, Alexandros D.
    Vervita, Vasiliki
    Koufogiannis, Kleanthis D.
    Adonakis, George
    Decavalas, George
    Georgopoulos, Neoklis A.
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 161 (02) : 317 - 322
  • [33] Increased insulin clearance in peroxisome proliferator-activated receptor γ2 Pro12Ala
    Tschritter, O
    Fritsche, A
    Stefan, N
    Haap, M
    Thamer, C
    Bachmann, O
    Dahl, D
    Maerker, E
    Teigeler, A
    Machicao, F
    Häring, H
    Stumvoll, M
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2003, 52 (06): : 778 - 783
  • [34] Lack of an association between peroxisome proliferator-activated receptor-γ gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome
    Orio, F
    Palomba, S
    Cascella, T
    Di Biase, S
    Labella, D
    Russo, T
    Savastano, S
    Zullo, F
    Colao, A
    Vettor, R
    Lombardi, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10): : 5110 - 5115
  • [35] Meta-analysis of the association of peroxisome proliferator-activated receptor (PPAR-gamma) Pro12Ala polymorphism with body mass index: a potential marker for diabetic tendency.
    Roberts, LL
    Coresh, J
    Hetmanski, J
    Beaty, TH
    AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 71 (04) : 359 - 359
  • [36] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ/PRO12ALA POLYMORPHISM AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ COACTIVATOR-1 ALPHA/GLY482SER POLYMORPHISM IN PATIENTS WITH SARCOIDOSIS
    Maver, A.
    Medica, I.
    Salobir, B.
    Tercelj-Zorman, M.
    Sabovic, M.
    Petrovic, D.
    Peterlin, B.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2008, 25 (01) : 29 - 35
  • [37] Correlation of Peroxisome Proliferator-Activated Receptor (PPAR-γ) mRNA Expression with Pro12Ala Polymorphism in Obesity
    Berhouma, Rym
    Kouidhi, Soumaya
    Ammar, Myriam
    Abid, Hafawa
    Ennafaa, Hajer
    Benammar-Elgaaied, Amel
    BIOCHEMICAL GENETICS, 2013, 51 (3-4) : 256 - 263
  • [38] Peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk
    Wang, Wei
    Shao, Yan
    Tang, Shenhua
    Cheng, Xianyong
    Lian, Haifeng
    Qin, Chengyong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (03): : 4066 - 4072
  • [39] The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 is not associated with type 2 diabetes
    Andersen, G
    Ek, J
    Urhammer, SA
    Eiberg, H
    Borch-Johnsen, K
    Hansen, T
    Pedersen, O
    DIABETOLOGIA, 2000, 43 : A87 - A87
  • [40] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-γ Pro12Ala POLYMORPHISM AND RISK OF OSTEOPENIA IN β-THALASSEMIA MAJOR PATIENTS
    Sahmani, Mehdi
    Gholami, Abdollah
    Azarkeivan, Azita
    Darabi, Masoud
    Ahmadi, Mohammad Hossein
    Sabet, Majid Sirati
    Najafipour, Reza
    HEMOGLOBIN, 2013, 37 (06) : 564 - 573